Interestingly, PDA cells treated with the CDK4/6 Inhibitor Palbociclib (PD-0332991) activate Rb as expected and also exhibit lower total Rb protein [45] as do cells with G1 arrest induced by other means [46]. This evidence concerns the gene RB1 and Patent ductus arteriosus.